Division of Enteric Bacterial Infections, Center for Infectious Diseases, Korea National Institute of Health, Osong, Korea.
Copyright ©2013, Korea Centers for Disease Control and Prevention
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antimicrobial agents |
Antibiotic resistances (%) of isolates
|
|
---|---|---|
Fishery workers | Control groups | |
β-Lactams | ||
Ampicillin | 29 | 34 |
β-Lactam/β-lactamase inhibitor combinations | ||
Ampicillin–sulbactam | 14 | 23 |
Piperacillin–tazobactam | 0 | 0 |
Cephems | ||
Cephalothin* | 36 | 0 |
Cefepime | 0 | 0 |
Cefotetan | 1 | 0 |
Cefotaxime | 0 | 1 |
Cefoxitin | 5 | 13 |
Carbapenems | ||
Imipenem | 0 | 0 |
Aminoglycosides | ||
Amikacin | 0 | 0 |
Gentamicin | 15 | 9 |
Tobramycin | 1 | 5 |
Netilamicin | 1 | 0 |
Tetracyclines | ||
Tetracycline* | 60 | 41 |
Monobactams | ||
Aztreonam | 0 | 2 |
Folate pathway inhibitors | ||
Trimethoprim–sulfamethoxazole* | 29 | 1 |